BrightView (NYSE: BV) CEO discloses 94,044 RSU grant and 1,052,610 share stake

Rhea-AI Filing Summary

BrightView Holdings, Inc. reported insider equity activity by its President and CEO. On December 1, 2025, the executive received a grant of 94,044 restricted stock units (RSUs), each representing a right to one share of common stock, vesting in four equal annual installments beginning December 1, 2026. On December 2, 2025, 28,851 RSUs vested and converted into common shares, increasing the executive’s direct holdings.

Also on December 2, 2025, 11,353 shares of common stock were withheld at $12.78 per share to cover related tax liabilities from the RSU vesting. After these transactions, the executive directly owned 1,052,610 shares of BrightView common stock, which includes shares from the employee stock purchase plan and unvested restricted stock but excludes unearned performance shares. A remaining balance of 86,556 RSUs is shown as beneficially owned, scheduled to vest over future years.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Asplund Dale A

(Last) (First) (Middle)

C/O BRIGHTVIEW HOLDINGS, INC.

980 JOLLY ROAD, SUITE 300

(Street)

BLUE BELL PA 19422

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightView Holdings, Inc. [ BV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/02/2025		M		28,851	A	(1)	1,063,963(2)	D
Common Stock	12/02/2025		F(3)		11,353	D	$12.78	1,052,610(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(4)	12/01/2025		A		94,044		(5)	(5)	Common Stock	94,044	$0	94,044	D
Restricted Stock Units	(4)	12/02/2025		M			28,851	(6)	(6)	Common Stock	28,851	$0	86,556	D

Explanation of Responses:

1. Reflects restricted stock units that upon vesting converted into shares of Issuer common stock on a one-for-one basis.

2. Includes shares of common stock acquired under the Issuer's employee stock purchase plan and unvested shares of restricted stock. Does not inlcude unvested performance shares which will be reported when earned upon achievement of certain performance criteria.

3. Represents the number of shares of common stock withheld to pay the realted tax liability on restricted stock units that vested on December 2, 2025.

4. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in either common stock or cash (or a combination thereof).

5. Represents a grant of time-based restricted stock units that vest in four equal annual installments beginning on December 1, 2026.

6. Represents a grant of time-based restricted stock units that vest in four equal annual installments beginning on December 2, 2025.

	/s/ Jonathan M. Gottsegen, as Attorney-in-Fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.